Identifying and validating biomarkers for Alzheimer's disease

Cited by (484)

Items 101–200 of 484

1. Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study
   Josef Marksteiner, Douglas Imarhiagbe, Michaela Defrancesco, E Deisenhammer, Georg Kemmler, Christian Humpel · 2013 · Experimental Gerontology
2. Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression
   Yang, Hongqian, Lyutvinskiy, Yaroslav, Herukka, Sanna-Kaisa, Soininen, Hilkka, Rutishauser, Dorothea, Zubarev, Roman A. · 2014 · Journal of Alzheimer's Disease
3. Lipidomics of Alzheimer’s Disease
   David Touboul, Mathieu Gaudin · 2014 · Bioanalysis
4. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases
   Meire Silva Batistela, Nalini Drieli Josviak, Carla Daniela Sulzbach, Ricardo Lehtonen Rodrigues de Souza · 2016 · International Journal of Neuroscience
5. Alzheimer's disease and blood-based biomarkers – potential contexts of use
   Martina Zvěřová · 2018 · Neuropsychiatric Disease and Treatment
6. Electrochemical detection of amyloid-β oligomer with the signal amplification of alkaline phosphatase plus electrochemical–chemical–chemical redox cycling
   Lin Liu, Ning Xia, Mengsha Jiang, Nanbing Huang, Shuo Guo, Sujuan Li, Shenglu Zhang · 2015 · Journal of Electroanalytical Chemistry
7. Predicting Dementia With Prefrontal Electroencephalography and Event-Related Potential
   Dieu Ni Thi Doan, Boncho Uk Ku, Jung-Mi Choi, Miae Oh, Kahye Kim, Wonseok Cha, Jaeuk U. Kim · 2021 · Frontiers in Aging Neuroscience
8. Chitosan mediated layer-by-layer assembly based graphene oxide decorated surface plasmon resonance biosensor for highly sensitive detection of β-amyloid
   Sopan Nangare, Pravin Onkar Patil · 2022 · International Journal of Biological Macromolecules
9. A Survey on Classification Algorithms of Brain Images in Alzheimer’s Disease Based on Feature Extraction Techniques
   Ruhul Amin Hazarika, Arnab Kumar Maji, Samarendra Nath Sur, Babu Sena Paul, Debdatta Kandar · 2021 · IEEE Access
10. Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
    Christian Humpel · 2011 · World Journal of Psychiatry
11. Robust EEG Based Biomarkers to Detect Alzheimer’s Disease
    Ali H. Husseen Al-Nuaimi, Marina Blūma, Shaymaa Al-Juboori, Chima S. Eke, Emmanuel Jammeh, Lingfen Sun, Emmanuel Ifeachor · 2021 · Brain Sciences
12. Cerebrospinal Fluid Tau Cleaved by Caspase-6 Reflects Brain Levels and Cognition in Aging and Alzheimer Disease
    Ramcharitar, Jasmine, Albrecht, Steffen, Afonso, Veronica M., Kaushal, Vikas, Bennett, David A., LeBlanc, Andrea C. · 2013 · Journal of Neuropathology & Experimental Neurology
13. Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
    Cole Schaffer, Nakia Sarad, Ashton DeCrumpe, Disha Goswami, Sara Herrmann, Jose Morales, Parth Patel, Jim Osborne · 2014 · SLAS TECHNOLOGY
14. Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
    Paloma Monllor, Ana Cervera‐Ferri, María-Ángeles Lloret, Daniel Esteve, Begoña Lopez, Jose-Luis Leon, Ana Lloret · 2021 · International Journal of Molecular Sciences
15. The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer’s Disease
    Kimberly Barber, Patricia Mendonca, Karam F. A. Soliman · 2023 · Brain Sciences
16. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer’s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry
    San Ha Kim, Joon Seon Yang, Jong Cheol Lee, Ji-Yeon Lee, Jun‐Young Lee, Eosu Kim, Myeong Hee Moon · 2018 · Journal of Chromatography A
17. Complementarity of Matrix- and Nanostructure-Assisted Laser Desorption/Ionization Approaches
    Paweł Pomastowski, Bogusław Buszewski · 2019 · Nanomaterials
18. Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases
    Dik‐Lung Ma, Wu Chun, Guodong Li, Tsan-Ling Yung, Chung‐Hang Leung · 2020 · Journal of Materials Chemistry B
19. Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
    Mirjana Babić Leko, Dubravka Švob Štrac, Dorotea Mück‐Šeler, Nela Pivac, Gabrijela Stanić, Patrick R. Hof, Goran Šimić · 2014 · Croatian Medical Journal
20. Genome‐wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology
    Kwangsik T. Nho, Kelly Nicole Holohan Nudelman, Mariet Allen, Angela Hodges, Sungeun Kim, Shannon L. Risacher, Liana G. Apostolova, Kuang Lin, Katie Lunnon, Xue Wang et al. · 2020 · Alzheimer s & Dementia
21. Subgroup identification in clinical trials via the predicted individual treatment effect
    Nicolás M. Ballarini, Gerd K. Rosenkranz, Thomas Jaki, Franz König, Martin Posch · 2018 · PLoS ONE
22. A metabolite panel that differentiates Alzheimer's disease from other dementia types
    Longfei Jia, Jianwei Yang, Min Zhu, Yana Pang, Qi Wang, Qin Wei, Ying Li, Tingting Li, Fangyu Li, Qigeng Wang et al. · 2021 · Alzheimer s & Dementia
23. Proteomic Analysis of Cerebrospinal Fluid in Alzheimer's Disease: Wanted Dead or Alive
    Zita Galik-Olah, Janos L. Kalman, Melinda E. Tóth, Ágnes Zvara, Miklós Sántha, Eszter Ivitz, Zoltán Janka, Magdolna Pákáski · 2015 · Journal of Alzheimer s Disease
24. Microfluidic Pipette Tip for High-Purity and High-Throughput Blood Plasma Separation from Whole Blood
    Byeongyeon Kim, Sein Oh, Dongwon You, Sungyoung Choi · 2017 · Analytical Chemistry
25. A label-free and signal-on electrochemiluminescence strategy for sensitive amyloid-beta assay
    Haixin Qin, Xue Ping Gao, Xiaoyan Yang, Wei Cao, Shufeng Liu · 2019 · Biosensors and Bioelectronics
26. Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases
    Arjan Malekzadeh, Vincent de Groot, Heleen Beckerman, Bob W. van Oosten, Marinus A. Blankenstein, Charlotte Elisabeth Teunissen · 2012 · Methods
27. Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide
    Zijian Zhao, Ling Zhu, Xiangli Bu, Huailei Ma, Shuhua Yang, Yanlian Yang, Zhiyuan Hu · 2014 · Chemical Communications
28. Gout and dementia in the elderly: a cohort study of Medicare claims
    Jasvinder A. Singh, John David Cleveland · 2018 · BMC Geriatrics
29. Metabolomic‐guided discovery of Alzheimer's disease biomarkers from body fluid
    Che Nor Adlia Enche Ady, Siong Meng Lim, Lay Kek Teh, Mohd Zaki Salleh, Ai‐Vyrn Chin, Maw Pin Tan, Philip J. H. Poi, Shahrul Bahyah Kamaruzzaman, Abu Bakar Abdul Majeed, Kalavathy Ramasamy · 2017 · Journal of Neuroscience Research
30. Can the retina be used to diagnose and plot the progression of Alzheimer's disease?
    Deepti Mahajan, Marcela Votruba · 2017 · Acta Ophthalmologica
31. Biomarkers: Role and Scope in Neurological Disorders
    Vivek Sharma, Thakur Gurjeet Singh, Vineet Mehta, Ashi Mannan · 2023 · Neurochemical Research
32. Dysregulation and Diagnostic Potential of microRNA in Alzheimer’s Disease
    Yaoqian Pan, Ruizhu Liu, Erin J.M. Terpstra, Yanqing Wang, Fangfang Qiao, Jin Wang, Yigang Tong, Bo Pan · 2015 · Journal of Alzheimer s Disease
33. Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer’s Disease
    Martínez de Toda, Irene, Miguélez, Lara, Vida, Carmen, Carro, Eva, De la Fuente, Mónica · 2019 · Journal of Alzheimer s Disease
34. Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
    Syed Haris Omar, John Preddy · 2020 · Journal of Personalized Medicine
35. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus
    Anri Sakurai, Taiji Tsunemi, Yuta Ishiguro, Ayami Okuzumi, Taku Hatano, Nobutaka Hattori · 2021 · Journal of Neurology
36. Integrated approach toward the discovery of glyco‐biomarkers of inflammation‐related diseases
    Takashi Angata, Reiko Fujinawa, Ayako Kurimoto, Kazuki Nakajima, Masaki Kato, Shinji Takamatsu, Hiroaki Korekane, Congxiao Gao, Kazuaki Ohtsubo, Shinobu Kitazume et al. · 2012 · Annals of the New York Academy of Sciences
37. Clinical applications of MS‐based protein quantification
    Bassel Sabbagh, Sonani Mindt, Michael Neumaier, Peter Findeisen · 2016 · PROTEOMICS - CLINICAL APPLICATIONS
38. CSF biomarkers in neurodegenerative and vascular dementias
    Franc Llorens, Matthias Schmitz, Isidró Ferrer, Inga Zerr · 2016 · Progress in Neurobiology
39. Identification of prefrontal cortex protein alterations in Alzheimer’s disease
    María Garranzo‐Asensio, Pablo San Segundo‐Acosta, Javier Martínez‐Useros, Ana Montero‐Calle, María Jesús Fernández‐Aceñero, Anna Månberg, Alberto Peláez‐García, Mayte Villalba, Alberto Rábano, Peter Nilsson et al. · 2018 · Oncotarget
40. Biomarkers in vascular dementia: A recent update
    Abhijeet Jagtap, Sonal Gawande, Sushil Kumar Sharma · 2014 · Biomarkers and Genomic Medicine
41. Variability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing
    Andrew D. Watt, Keyla A. Perez, Alan Rembach, Colin Louis Masters, Victor L. Villemagne, Kevin Jeffrey Barnham · 2012 · Journal of Alzheimer s Disease
42. Voice biomarkers as indicators of cognitive changes in middle and later adulthood
    Elizabeth Mahon, Margie E. Lachman · 2022 · Neurobiology of Aging
43. Biomarkers: Our Path Towards a Cure for Alzheimer Disease
    Rawan M. Tarawneh · 2020 · Biomarker Insights
44. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer’s disease in patients with the apolipoprotein E ε4 genotype
    Chao Wang, Yongjian Cui, Jingci Yang, Jinrong Zhang, Dongcai Yuan, Yan Wei, Yumei Li, Yali Duo, Shengjun Li, Wenyi Zhu et al. · 2014 · Biomarkers
45. Alzheimer's Disease—Current Status and Future Directions
    Deepshikha Bhardwaj, Connie Mitra, Chandrakala Aluganti Narasimhulu, Aladdin Riad, Mitsushita Doomra, Sampath Parthasarathy · 2017 · Journal of Medicinal Food
46. Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers
    Jaeyoon Song, Eunseo Cho, Huiseop Lee, Suyoung Lee, Sehyeon Kim, Jinsik Kim · 2025 · Biosensors
47. Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation
    Thanh Duc Mai, Iago Pereiro, Mohamed Hiraoui, Jean‐Louis Viovy, Stéphanie Descroix, Myriam Taverna, Claire Smadja · 2015 · The Analyst
48. Detection of Amyloid-β42 Using a Waveguide-Coupled Bimetallic Surface Plasmon Resonance Sensor Chip in the Intensity Measurement Mode
    Yeon Kyung Lee, Kyeong-Seok Lee, Won Mok Kim, Young‐Soo Sohn · 2014 · PLoS ONE
49. Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis
    Jana Janssens, Yannick Vermeiren, Erik Fransén, Tony Aerts, Debby Van Dam, Sebastiaan Engelborghs, Peter Paul De Deyn · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
50. Circulating microRNAs as novel biomarkers of Alzheimer's disease
    Mustapha Zendjabil · 2018 · Clinica Chimica Acta
51. Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
    Md. Sohanur Rahman, Md. Sahab Uddin, Md. Ataur Rahman, Md. Samsuzzaman, Tapan Behl, Abdul Hafeez, Asma Perveen, George Emilio Barreto, Ghulam Md Ashraf · 2021 · Current Pharmaceutical Design
52. Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer’s disease-relevant murine model
    Rosemary A. Schuh, Kathryn C. Jackson, Anna E Schlappal, Espen E. Spangenburg, Christopher W. Ward, Ji Hyun Park, Natalie V. Dugger, Guoli Shi, Paul S. Fishman · 2014 · BMC Neuroscience
53. Optical biosensors for diagnosing neurodegenerative diseases
    Khuong Duy Mac, Judith Su · 2025 · npj Biosensing
54. Using Biomarkers to Improve Detection of Alzheimer’s Disease
    Milton Cesar Biagioni, James E. Galvin · 2011 · Neurodegenerative Disease Management
55. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
    Longfei Jia, Min Zhu, Jianwei Yang, Yana Pang, Qi Wang, Ying Li, Tingting Li, Fangyu Li, Qigeng Wang, Yan Li et al. · 2021 · BMC Medicine
56. Saliva: a challenging human fluid to diagnose brain disorders with a focus on Alzheimer’s disease
    Christine Zürcher, Christian Humpel · 2023 · Neural Regeneration Research
57. Hemodynamic and serum cardiac markers and risk of cognitive impairment and dementia
    Isabelle F. van der Velpen, Stephanie Feleus, Anne Suzanne Bertens, Behnam Sabayan · 2016 · Alzheimer s & Dementia
58. Alzheimer’s Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers
    Shraddha Sapkota, Tao Huan, Tran Tran, Jiamin Zheng, Richard M. Camicioli, Liang Li, Roger A. Dixon · 2018 · Frontiers in Aging Neuroscience
59. Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays
    del Campo, Marta, Jongbloed, Wesley, Twaalfhoven, Harry A. M., Veerhuis, Robert, Blankenstein, Marinus A., Teunissen, Charlotte E. · 2015 · Frontiers in Neurology
60. Next-generation biomarker discovery in Alzheimer’s disease using metabolomics–from animal to human studies
    Hurtado, Marina Ollé, Kohler, Isabelle, de Lange, Elizabeth C M · 2018 · Bioanalysis
61. sMRI-PatchNet: A Novel Efficient Explainable Patch-Based Deep Learning Network for Alzheimer’s Disease Diagnosis With Structural MRI
    Xin Zhang, Liangxiu Han, Lianghao Han, Haoming Chen, Darren Dancey, Daoqiang Zhang · 2023 · IEEE Access
62. The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging
    Theodore A. Henderson · 2012 · CNS Spectrums
63. The antioxidant effects of hedysarum polybotrys polysaccharide in extending lifespan and ameliorating aging-related diseases in Drosophila melanogaster
    Shipei Yang, Minghui Xiu, Xu Li, Yan Shi, Shuwei Wang, Shengfang Wan, Shuzhen Han, Dan Yang, Yongqi Liu, Jianzheng He · 2023 · International Journal of Biological Macromolecules
64. Fabrication of thioflavin‐ T ‐modified nanopillared SERS substrates for ultrasensitive beta‐amyloid peptide detection
    Sevde Altuntaş, Fatih Büyükserin · 2018 · Journal of Raman Spectroscopy
65. A Network-Based Perspective in Alzheimer's Disease: Current State and an Integrative Framework
    Andrei Dragomir, Aristidis G. Vrahatis, Anastasios Bezerianos · 2018 · IEEE Journal of Biomedical and Health Informatics
66. The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
    Wei‐Chieh Weng, Wen‐Yi Huang, Hsiang-Yu Tang, Mei‐Ling Cheng, Kuan‐Hsing Chen · 2019 · Frontiers in Neurology
67. Proteomic Technologies for Biomarker Studies in Psychiatry
    Daniel Martins‐de‐Souza, Paul C. Guest, Natacha Vanattou‐Saïfoudine, Laura Wiseman Harris, Sabine Bahn · 2011 · International review of neurobiology
68. A graphene oxide-based fluorescent platform for selective detection of amyloid-β oligomers
    Lin Liu, Ning Xia, Jiebin Zhang, Wenhui Mao, Yangyang Wu, Xingxing Ge · 2015 · Analytical Methods
69. Progress and challenges in the diagnosis of dementia: a critical review
    Paraskevaidi, Maria, Martin-Hirsch, Pierre L., Martin, Francis L. · 2018 · ACS Chemical Neuroscience
70. Fluorescent peptide nanoparticles to detect amyloid-beta aggregation in cerebrospinal fluid and serum for Alzheimer’s disease diagnosis and progression monitoring
    Sun, Leming, Liu, Dingchang, Fu, Dongjie, Yue, Tao, Scharre, Douglas, Zhang, Lianbing · 2021 · Chemical Engineering Journal
71. Blood-based redox-signature and their association to the cognitive scores in MCI and Alzheimer’s disease patients
    Morgane Perrotte, Aurélie Y. Le Page, Marianne Fournet, Mélanie Le Sayec, Éric Rassart, Tamàs Fülöp, Charles Ramassamy · 2018 · Free Radical Biology and Medicine
72. Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer’s Disease: Development and Future Prospects
    Sopan Nangare, Pravin Onkar Patil · 2021 · Critical Reviews in Analytical Chemistry
73. Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects
    Hochstrasser, Tanja, Marksteiner, Josef, Defrancesco, Michaela, Deisenhammer, Eberhard A., Kemmler, Georg, Humpel, Christian · 2011 · Dementia and Geriatric Cognitive Disorders Extra
74. Metals, Membranes, and Amyloid-β Oligomers: Key Pieces in the Alzheimer's Disease Puzzle?
    Andrew D. Watt, Victor L. Villemagne, Kevin Jeffrey Barnham · 2012 · Journal of Alzheimer s Disease
75. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications
    Marcella Reale, Isabella Gonzales-Portillo, Cesar V. Borlongan · 2019 · Brain Research
76. Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
    Josef Marksteiner, Michaela Defrancesco, Christian Humpel · 2022 · Frontiers in Aging Neuroscience
77. FDG–PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease
    Bettina Platt, Andy Welch, Gernot Riedel · 2011 · Biochemical Society Transactions
78. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer’s Disease
    Hye Youn Sung, Byung‐Ok Choi, Jee Hyang Jeong, Kyoung Ae Kong, Jinha Hwang, Jung‐Hyuck Ahn · 2016 · PLoS ONE
79. Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literature
    Victoria S. Marshe, Ilona Gorbovskaya, Sarah Kanji, Maxine Kish, Daniel J. Müller · 2018 · Journal of Neural Transmission
80. Exosomal MicroRNA-Based Predictive Model for Preclinical Alzheimer’s Disease: A Multicenter Study
    Longfei Jia, Min Zhu, Jianwei Yang, Yana Pang, Qi Wang, Tingting Li, Fangyu Li, Qigeng Wang, Yan Li, Yiping Wei · 2022 · Biological Psychiatry
81. Raman spectroscopy and multivariate analysis as potential tool to follow Alzheimer’s disease progression
    Angela Gilda Carota, Beatrice Campanella, Renata Del Carratore, Paolo Bongioanni, Roberta Giannelli, Stefano Legnaioli · 2022 · Analytical and Bioanalytical Chemistry
82. Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond
    Giuseppe Grasso · 2018 · Mass Spectrometry Reviews
83. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
    Stephanie M. Williams, Galam Khan, Brent T. Harris, John Ravits, Michael R. Sierks · 2017 · BMC Neuroscience
84. Biomarkers in Alzheimer’s disease
    Manuel H. Janeiro, Carlos G. Ardanaz, Noemí Sola-Sevilla, Jinya Dong, María Cortés-Erice, Maite Solas, Elena Puerta, María Javier Ramírez · 2020 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
85. Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
    Katja Kühbach, Maren Hülsemann, Yvonne Herrmann, Kateryna Kravchenko, Andreas Kulawik, Christina Linnartz, Luriano Peters, Kun Wang, Johannes Willbold, Dieter Willbold et al. · 2016 · Frontiers in Neuroscience
86. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer’s Disease
    Renã A. S. Robinson, Bushra Amin, Paul C. Guest · 2017 · Advances in experimental medicine and biology
87. Characterizing Alzheimer's disease through metabolomics and investigating anti‐Alzheimer's disease effects of natural products
    Lunzhao Yi, Wenbin Liu, Zhe Wang, Dabing Ren, Weijun Peng · 2017 · Annals of the New York Academy of Sciences
88. Hollow core photonic crystal fiber-assisted Raman spectroscopy as a tool for the detection of Alzheimer’s disease biomarkers
    Pinkie Jacob Eravuchira, Martina Banchelli, Cristiano D’Andrea, Marella de Angelis, Paolo Matteini, Israel Gannot · 2020 · Journal of Biomedical Optics
89. Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
    Yangyang Wang, Yanping Sun, Yumeng Luo, Donghui Peng, Xiao Li, Bing‐You Yang, Qiuhong Wang, Haixue Kuang · 2021 · Frontiers in Pharmacology
90. DNAzyme-driven bipedal DNA walker triggered to hybridize silver nanoparticle probes for electrochemical detection of amyloid-β oligomer
    Chenyi Zhuo, Zheng Li, Jiuying Cui, Zichun Song, Qianli Tang, Yiming Yin, Guanqun Zhang, Xianjiu Liao, Zhao Liu, Fenglei Gao · 2023 · Analytica Chimica Acta
91. The elusive nature and diagnostics of misfolded Aβ oligomers
    Eleonora Cerasoli, Maxim G. Ryadnov, Brian Austen · 2015 · Frontiers in Chemistry
92. ATR-FTIR Spectroscopy Tools for Medical Diagnosis and Disease Investigation
    Maria Paraskevaidi, Pierre L. Martin‐Hirsch, Francis L. Martin · 2018 · Springer eBooks
93. Infrared spectroscopic analysis of mononuclear leukocytes in peripheral blood from Alzheimer’s disease patients
    P. Carmona, Marina Molina, Miguel Calero, Félix Bermejo‐Pareja, Pablo Martínez‐Martín, Isabel Álvarez, A. Tolédano · 2012 · Analytical and Bioanalytical Chemistry
94. Poor memory performance in aged cynomolgus monkeys with hippocampal atrophy, depletion of amyloid beta 1-42 and accumulation of tau proteins in cerebrospinal fluid.
    Huda Shalahudin Darusman, Jacub Pandelaki, Rahmad Mulyadi, Dondin Sajuthi, Indah Aprianti Putri, Otto Kalliokoski, Josep Call, Klas Abelson, Steven J. Schapiro, ALBERT H. GJEDDE et al. · 2014 · PubMed
95. Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer’s disease diagnosis and prognosis
    Tao Yue, Xinghua Jia, Jennifer M. Petrosino, Leming Sun, Zhen Fan, Jesse N. Fine, Rebecca Davis, Scott M. Galster, Jeff Kuret, Douglas W. Scharre et al. · 2017 · Science Advances
96. Quantitative evaluation of the dynamic activity of HeLa cells in different viability states using dynamic full-field optical coherence microscopy
    Soongho Park, Thien Duy Nguyen, Émilie Benoit à la Guillaume, Dan L. Sackett, Marcial Garmendia‐Cedillos, Randall H. Pursley, Claude Boccara, Amir Gandjbakhche · 2021 · Biomedical Optics Express
97. Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment
    Gabriel González‐Escamilla, Mercedes Atienza, David García-Solís, José Luis Cantero · 2014 · Brain Structure and Function
98. Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer's disease
    Yuanshuai Zhou, Zhongjuan Xu, Yanzhen Yu, Junjun Cao, Yong Qiao, Hong Qiao, Guangli Suo · 2019 · Molecular Omics
99. Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond
    Bayu Tri Murti, Athika Darumas Putri, Yi‐June Huang, Shih-Min Wei, Chih‐Wei Peng, Po‐Kang Yang · 2021 · RSC Advances
100. Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
     Janine Utz, Judith Berner, Luis Enrique Munoz, Timo Jan Oberstein, Johannes Kornhuber, Martin Herrmann i, Juan Manuel Maler, Philipp Spitzer · 2021 · Frontiers in Aging Neuroscience